Across the recent three months, 14 analysts have shared their insights on AbbVie (NYSE:ABBV), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Insights from analysts’ 12-month price targets are revealed, presenting an average target of $201.21, a high estimate of $218.00, and a low estimate of $185.00. This current average reflects an increase of 3.18% from the previous average price target of $195.00. Exploring …